Cardiol Therapeutics Inc. (OTCMKTS:CRTPF – Get Free Report) shares were up 2.1% during mid-day trading on Thursday . The stock traded as high as $1.95 and last traded at $1.94. Approximately 371,750 shares were traded during trading, an increase of 454% from the average daily volume of 67,097 shares. The stock had previously closed at $1.90.
Cardiol Therapeutics Stock Down 1.0 %
The firm has a fifty day simple moving average of $2.03 and a 200 day simple moving average of $2.08.
Cardiol Therapeutics Company Profile
Cardiol Therapeutics Inc is a clinical-stage biotechnology company that focuses on the research and clinical development of anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its product, CardiolRx, is a pharmaceutically produced extra strength oral cannabidiol formulation that is entering a Phase II/III outcomes study in hospitalized patients testing positive for the COVID-19 virus.
See Also
- Five stocks we like better than Cardiol Therapeutics
- Trading Halts Explained
- Misses and Beats: 3 Stocks That Are Moving Markets Right Now
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Cisco on the Rise: AI Potential and Analyst Upgrades Drive Gains
- Consumer Staples Stocks, Explained
- MarketBeat Week in Review – 10/14 – 10/18
Receive News & Ratings for Cardiol Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardiol Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
